Longevity pharmaceutical company Enlivex secures $21 million in debt financing.

PANews reported on March 24th that Enlivex , a longevity medicine and RAIN token repository, announced it has secured $ 21 million in debt financing from New York-based institutional investor The Lind Partners . The company stated it will continue its prediction market token repository strategy, adding approximately 3 billion new RAIN tokens to support its operational plans. Enlivex , a Nasdaq-listed company, is developing therapies for joint diseases such as osteoarthritis and holds a large RAIN position as its digital asset repository. RAIN is a decentralized prediction market protocol token deployed on the Arbitrum network, whose protocol uses AI to determine results and employs a buyback and burn mechanism. Enlivex's stock price is currently around $ 1.05 , down approximately 5% today.